Scholarlink

Background <p>Previous studies have demonstrated that patients with Parkinson’s disease (PD) exhibit pathologically increased beta band activity (12–35&#xa0;Hz) in the basal ganglia, which peaks at an individual frequency and correlates with symptom severity. The purpose of this study was to determine whether different beta peak measures can serve as predictors for deep brain stimulation (DBS) contact selection.</p> Methods <p>Subthalamic local field potentials were acquired from 27 patients with PD (8 female, 59.0 ± 8.9 years) with (ON) and without (OFF) dopaminergic medication. Peak amplitudes and frequencies were detected in the low (12–20&#xa0;Hz) and high beta band (21–35&#xa0;Hz), and their predictive value for the motor symptom improvement, the therapeutic window and the optimal stimulation contact were analyzed.</p> Results <p>In particular, the power ratio of the highest low beta peak ON versus OFF medication explained 23.7% of the variance in the therapeutic window.</p> Conclusion <p>Our results demonstrate that beta peak measures can serve as valuable markers to estimate contact selection to achieve an optimal DBS outcome in patients with PD.</p> Trial registration <p>Not applicable.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Subthalamic beta peak power ratio as an electrophysiological marker for deep brain stimulation contact selection in Parkinson’s disease

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月28日

查看全文
  • Victoria D. M. Molinari,
  • Matthias Sure,
  • Rachel K. Spooner,
  • Bahne H. Bahners,
  • Alfons Schnitzler,
  • Esther Florin,
  • Christian J. Hartmann

摘要

Background

Previous studies have demonstrated that patients with Parkinson’s disease (PD) exhibit pathologically increased beta band activity (12–35 Hz) in the basal ganglia, which peaks at an individual frequency and correlates with symptom severity. The purpose of this study was to determine whether different beta peak measures can serve as predictors for deep brain stimulation (DBS) contact selection.

Methods

Subthalamic local field potentials were acquired from 27 patients with PD (8 female, 59.0 ± 8.9 years) with (ON) and without (OFF) dopaminergic medication. Peak amplitudes and frequencies were detected in the low (12–20 Hz) and high beta band (21–35 Hz), and their predictive value for the motor symptom improvement, the therapeutic window and the optimal stimulation contact were analyzed.

Results

In particular, the power ratio of the highest low beta peak ON versus OFF medication explained 23.7% of the variance in the therapeutic window.

Conclusion

Our results demonstrate that beta peak measures can serve as valuable markers to estimate contact selection to achieve an optimal DBS outcome in patients with PD.

Trial registration

Not applicable.